| 000 | 01619 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515123116.0 | ||
| 264 | 0 | _c20080924 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a0301-0430 | ||
| 024 | 7 |
_a10.5414/cnp69425 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeidig, M | |
| 245 | 0 | 0 |
_aEfficacy, safety and tolerability of valsartan 80 mg compared to irbesartan 150 mg in hypertensive patients on long-term hemodialysis (VALID study). _h[electronic resource] |
| 260 |
_bClinical nephrology _cJun 2008 |
||
| 300 |
_a425-32 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 | _aIrbesartan |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 |
_aTetrazoles _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aValine _xanalogs & derivatives |
| 650 | 0 | 4 | _aValsartan |
| 700 | 1 | _aBambauer, R | |
| 700 | 1 | _aKirchertz, E J | |
| 700 | 1 | _aSzabã, T | |
| 700 | 1 | _aHandrock, R | |
| 700 | 1 | _aLeinung, D | |
| 700 | 1 | _aBaier, M | |
| 700 | 1 | _aSchmieder, R E | |
| 773 | 0 |
_tClinical nephrology _gvol. 69 _gno. 6 _gp. 425-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/cnp69425 _zAvailable from publisher's website |
| 999 |
_c18023951 _d18023951 |
||